InsiderFlow

ARTV

Artiva Biotherapeutics, Inc.$3.94-0.07 (-1.62%)
Prev Close$4.01·MCap$195.8M·P/E—·Vol1.07M·Yield—
▲

Buys (12M)

10

$109.18M

▼

Sells (12M)

26

$2.93M

◆

Net Activity

Net Buyer

$106.25M

●

Active Insiders

7

last 12 mo

Over the past 12 months, insider activity at Artiva Biotherapeutics, Inc. (ARTV) has been dominated by buying, with 10 insider purchases totaling $109.18M and 26 insider sales totaling $2.93M. The most recent insider transaction was by Bush Jennifer (officer: COO, CLO, Compliance Officer), who sold $35.3K worth of shares on Nov 3, 2026. Artiva Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $195.8M.

ARTV Insider Trading Activity

DateInsiderTypeValue
Nov 3, 2026 Bush JenniferSell$35.3K
Nov 3, 2026 Horan ChristopherSell$43.6K
Nov 3, 2026 Aslan FredSell$260.0K
Nov 3, 2026 Banerjee SubhashisSell$4.6K
Oct 7, 2026 Aslan FredSell$168.9K
Oct 6, 2026 Bush JenniferSell$57.2K
Oct 6, 2026 Banerjee SubhashisSell$7.5K
Oct 6, 2026 Aslan FredSell$421.8K
Oct 6, 2026 Horan ChristopherSell$70.7K
Sep 9, 2026 Aslan FredSell$255.7K
Sep 4, 2026 Aslan FredSell$690.4K
Sep 4, 2026 Banerjee SubhashisSell$12.3K
Sep 4, 2026 Horan ChristopherSell$115.6K
Sep 4, 2026 Bush JenniferSell$93.6K
Aug 31, 2026 Banerjee SubhashisSell$98.7K
Aug 19, 2026 Banerjee SubhashisSell$5.1K
Jul 31, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$455.7K
Jul 28, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$412.8K
Jul 23, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$2.64M1.1% OS
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$1.43M0.6% OS
Jul 14, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$194.0K
Jun 29, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$292.1K
Jun 16, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$4.60M2.1% OS
Jun 11, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$7.65M4.2% OS
May 28, 2026 GC Corp.Buy$16.50M5.8% OS
May 19, 2026 Raymon HeatherSell$27.9K
May 19, 2026 Aslan FredSell$244.3K
May 19, 2026 Banerjee SubhashisSell$63.4K
May 19, 2026 Horan ChristopherSell$63.1K
May 19, 2026 Bush JenniferSell$79.2K
May 13, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$75.00M26.3% OS
Feb 15, 2026 Aslan FredSell$58.4K
Feb 15, 2026 Bush JenniferSell$14.1K
Feb 15, 2026 Horan ChristopherSell$8.7K
Feb 15, 2026 Raymon HeatherSell$6.1K
Dec 15, 2025 Aslan FredSell$19.1K
Nov 15, 2025 Aslan FredSell$42.1K
Nov 15, 2025 Bush JenniferSell$9.9K
Nov 15, 2025 Horan ChristopherSell$6.2K
Nov 15, 2025 Krishnamohan NehaSell$11.3K
Nov 15, 2025 Raymon HeatherSell$4.5K
Oct 17, 2025 Aslan FredSell$153.0K
May 15, 2025 Aslan FredSell$91.4K
May 15, 2025 Bush JenniferSell$21.8K
May 15, 2025 Horan ChristopherSell$9.8K
May 15, 2025 Krishnamohan NehaSell$18.8K
May 15, 2025 Raymon HeatherSell$6.1K
Jul 22, 2024 Huh Yong-JunBuy$25.00M8.4% OS

ARTV Insider Buying Activity

The following table shows recent insider purchases of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Jul 31, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$455.7K
Jul 28, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$412.8K
Jul 23, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$2.64M1.1% OS
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$1.43M0.6% OS
Jul 14, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$194.0K
Jun 29, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$292.1K
Jun 16, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$4.60M2.1% OS
Jun 11, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$7.65M4.2% OS
May 28, 2026 GC Corp.Buy$16.50M5.8% OS
May 13, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$75.00M26.3% OS
Jul 22, 2024 Huh Yong-JunBuy$25.00M8.4% OS

ARTV Insider Selling Activity

The following table shows recent insider sales of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 3, 2026 Bush JenniferSell$35.3K
Nov 3, 2026 Horan ChristopherSell$43.6K
Nov 3, 2026 Aslan FredSell$260.0K
Nov 3, 2026 Banerjee SubhashisSell$4.6K
Oct 7, 2026 Aslan FredSell$168.9K
Oct 6, 2026 Bush JenniferSell$57.2K
Oct 6, 2026 Banerjee SubhashisSell$7.5K
Oct 6, 2026 Aslan FredSell$421.8K
Oct 6, 2026 Horan ChristopherSell$70.7K
Sep 9, 2026 Aslan FredSell$255.7K
Sep 4, 2026 Aslan FredSell$690.4K
Sep 4, 2026 Banerjee SubhashisSell$12.3K
Sep 4, 2026 Horan ChristopherSell$115.6K
Sep 4, 2026 Bush JenniferSell$93.6K
Aug 31, 2026 Banerjee SubhashisSell$98.7K
Aug 19, 2026 Banerjee SubhashisSell$5.1K
May 19, 2026 Raymon HeatherSell$27.9K
May 19, 2026 Aslan FredSell$244.3K
May 19, 2026 Banerjee SubhashisSell$63.4K
May 19, 2026 Horan ChristopherSell$63.1K
May 19, 2026 Bush JenniferSell$79.2K
Feb 15, 2026 Aslan FredSell$58.4K
Feb 15, 2026 Bush JenniferSell$14.1K
Feb 15, 2026 Horan ChristopherSell$8.7K
Feb 15, 2026 Raymon HeatherSell$6.1K
Dec 15, 2025 Aslan FredSell$19.1K
Nov 15, 2025 Aslan FredSell$42.1K
Nov 15, 2025 Bush JenniferSell$9.9K
Nov 15, 2025 Horan ChristopherSell$6.2K
Nov 15, 2025 Krishnamohan NehaSell$11.3K
Nov 15, 2025 Raymon HeatherSell$4.5K
Oct 17, 2025 Aslan FredSell$153.0K
May 15, 2025 Aslan FredSell$91.4K
May 15, 2025 Bush JenniferSell$21.8K
May 15, 2025 Horan ChristopherSell$9.8K
May 15, 2025 Krishnamohan NehaSell$18.8K
May 15, 2025 Raymon HeatherSell$6.1K

ARTV Insiders

Aslan Fred

President and CEO

Sold $2.41M
11 tradesLast: Nov 3, 2026
Bush Jennifer

officer: COO, CLO, Compliance Officer

Sold $311.0K
7 tradesLast: Nov 3, 2026
Banerjee Subhashis

officer: Chief Medical Officer

Sold $191.7K
6 tradesLast: Nov 3, 2026
Horan Christopher

officer: Chief Tech Operations Officer

Sold $317.7K
7 tradesLast: Nov 3, 2026
RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

Bought $92.68M
9 tradesLast: Jul 31, 2026
GC Corp.

10 percent owner

Bought $16.50M
1 tradesLast: May 28, 2026
Raymon Heather

SVP, Research and Development

Sold $44.5K
4 tradesLast: May 19, 2026
Krishnamohan Neha

Chief Financial Officer

Sold $30.2K
2 tradesLast: Nov 15, 2025
Huh Yong-Jun

Director

Bought $25.00M
1 tradesLast: Jul 22, 2024